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Abstract
Mitochondrial DNA (mtDNA) deletions are a common cause of mitochondrial disorders. Large mtDNA deletions can lead to
a broad spectrum of clinical features with different age of onset, ranging from mild mitochondrial myopathies (MM),
progressive external ophthalmoplegia (PEO), and Kearns-Sayre syndrome (KSS), to severe Pearson syndrome. The aim of this
study is to investigate the molecular signatures surrounding the deletion breakpoints and their association with the clinical
phenotype and age at onset. MtDNA deletions in 67 patients were characterized using array comparative genomic
hybridization (aCGH) followed by PCR-sequencing of the deletion junctions. Sequence homology including both perfect
and imperfect short repeats flanking the deletion regions were analyzed and correlated with clinical features and patients’
age group. In all age groups, there was a significant increase in sequence homology flanking the deletion compared to
mtDNA background. The youngest patient group (,6 years old) showed a diffused pattern of deletion distribution in size
and locations, with a significantly lower sequence homology flanking the deletion, and the highest percentage of deletion
mutant heteroplasmy. The older age groups showed rather discrete pattern of deletions with 44% of all patients over 6
years old carrying the most common 5 kb mtDNA deletion, which was found mostly in muscle specimens (22/41). Only 15%
(3/20) of the young patients (,6 years old) carry the 5 kb common deletion, which is usually present in blood rather than
muscle. This group of patients predominantly (16 out of 17) exhibit multisystem disorder and/or Pearson syndrome, while
older patients had predominantly neuromuscular manifestations including KSS, PEO, and MM. In conclusion, sequence
homology at the deletion flanking regions is a consistent feature of mtDNA deletions. Decreased levels of sequence
homology and increased levels of deletion mutant heteroplasmy appear to correlate with earlier onset and more severe
disease with multisystem involvement.
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Introduction
Mitochondria are energy producing cellular organelles that
contain their own genetic material, mitochondrial DNA (mtDNA).
Depending on energy demand of various tissues, there are
hundreds to thousands of mitochondria per cell, and each
mitochondrion contains 2–10 mtDNA molecules. Defects in
mtDNA cause mitochondrial disorders, predominantly affecting
tissues of high energy demand such as muscle and nerve. The
disease severity, in general, depends on the degree of mutant
heteroplasmy (mixture of wild type and mutant mtDNA molecules
within a cell) in affected tissues. Mitochondrial DNA deletions are
a common cause of mitochondrial disease and may contribute to
the process of normal aging [1]. MtDNA deletions were first
discovered in the skeletal muscle of patients with mitochondrial
myopathies (MM) and Kearns-Sayre syndrome (KSS) [2,3,4].
These patients typically present with progressive external opthal-
moplegia (PEO), pigmentary retinopathy, and one or more of the
following: cerebellar ataxia, a cardiac conduction defect, and
elevated protein concentration in the cerebrospinal fluid [5].
Although onset before the age of 20 is one of the diagnostic
criteria, many patients with PEO or MM without other KSS
symptoms often develop neuromuscular symptoms at a much
older age [6]. In contrast, symptoms in young children and infants
can be quite heterogeneous and severe. Many of these patients
develop Pearson syndrome, which is characterized by infantile
onset of sideroblastic anemia, with vacuolization of bone marrow
precursor cells and pancreatic dysfunction [7]. Patients who
survive infancy may develop KSS at a later age. Young patients
often exhibit a multisystem clinical presentation involving the
neuromuscular, hematologic, gastrointestinal, and metabolic
systems as well as growth failure. In contrast, patients with adult
onset mtDNA deletion syndromes exhibit mostly neuromuscular
and ophthalmologic symptoms [8]. Diagnostically, in young
patients it is possible to use the less invasive blood samples for
mtDNA deletion testing since the mtDNA molecules carrying
deletions are expected to be present in all tissues due to the severe
multisystem disorder. The deletion in young patients is most likely
a de novo germline or early embryonic event, whereas in older
patients, the mtDNA deletion most likely occurs somatically in the
affected tissue. Thus, the deletion mtDNA molecules are usually
not present in blood specimens and it is necessary to use muscle for
the detection of mtDNA deletion [8].
At the molecular level, the majority (approximately 60%) of
mtDNA deletions occur at a region that is flanked by short direct
repeat sequences, one of which is usually lost during the deletion
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15687process, and are referred to as class I deletions [9,10].
Approximately 30% of mtDNA deletions have been shown to be
flanked by imperfect repeats containing a few mismatches (class II
deletions), and about 10% have no repeats at the deletion flanking
regions [11]. The most common mtDNA deletion is a large 5 kb
deletion (m.8470-m.13447), which is present in approximately one
third of patients, and is flanked by a 13 nt class I direct repeat
[10]. Such repeats are thought to play a role in the formation of
mtDNA deletions. However, it is unclear what biological
mechanisms are directly responsible for these events. It is
speculated that defects in mtDNA replication caused by
inappropriate alignment of direct repeats may be the cause of
mtDNA deletions [12,13,14]. An alternative method involving the
repair of mtDNA damage has recently been proposed [15].
While the presence of an mtDNA deletion is a common feature
in patients with mtDNA deletion syndrome, the clinical features
can range from very mild, late-onset disorders affecting predom-
inantly neuromuscular tissues to very severe, multisystem disease
in infants who often succumb to the disease [8]. The objective of
this study was to characterize the molecular features associated
with mtDNA deletion syndromes, including levels of hetero-
plasmy, locations of deletions, presence of direct repeats, degree of
sequence homology at the breakpoints, and to correlate them with
the clinical features and age at diagnosis in a cohort of 67 patients
with mtDNA deletion syndrome.
Materials and Methods
Patient samples
This study involved the review and analysis of the clinical
information and molecular results of 67 patients who were
diagnosed with a mtDNA deletion syndrome. The detailed clinical
information and diagnoses are tabulated for each patient (Table
S1). The study was performed according to an Institutional
Review Board protocol for research on human subjects at the
Baylor College of Medicine.
Analysis of mtDNA deletions
Extracted DNA samples from blood or muscle were analyzed by
Southern blot for mtDNA deletions [16,17]. A majority of the
DNA samples were also analyzed by oligonucleotide array
comparative hybridization (aCGH) with the MitoMetH platform,
as previously described [18], in order to determine the location
and size of the deletion, as well as the degree of mtDNA deletion
heteroplasmy. In a small number of the cases, the level of
heteroplasmy was determined by densitometric analysis of the
Southern blot, the results of which were shown to be consistent
with the quantification by the MitoMetH aCGH method [18]. The
deletion junction sequences of all samples were further analyzed
by PCR amplification across the deletion junction, followed by
sequence analysis using the BigDye Terminator Cycle Sequencing
kit (version 3.1) and the ABI3730XL automated DNA sequencer
with Mutation Surveyor V3.20 software (Softgenetics, State
College, CA). A representative sample is shown in Figure S1.
The detailed 59 and 39 sequence position flanking the deletion
region and heteroplasmy data are tabulated for each sample
(Table S1.).
Analysis of sequence homology around the deletion
junction
Sequences of a total of 49 nucleotides surrounding the deletion
junction were aligned to proximal and distal sequences, 59 and 39
to the deletion region, respectively. Since the majority of deletion
junctions contain a short direct repeat that appears at both 59 and
39 sides of the junction, it is not possible to determine the exact
breakpoint. We therefore arbitrarily assign the breakpoint
nucleotide to the most 59 nucleotide of the short repeat. The
breakpoint nucleotide is easier to assign in cases where there is
zero or single nucleotide overlap. The sequence homology in the
49 nt region (24 nt on each side of the breakpoint nucleotide) of
the proximal and distal sequences was analyzed using ClustalW
software [19] with default parameters (http://www.ebi.ac.uk/
Tools/clustalw2/index.html). The choice of 24 nt on each side of
the breakpoint nucleotide is based on a recent review by McVey
and Lee, which shows that microhomology mediated end joining
(MMEJ) repair, a deletion-causing mechanism involving largest
regions of imperfect microhomology, includes perfect and
imperfect repeats ranging from 5 to 25 nucleotides flanking the
breakpoint [20]. The presence of a direct repeat at the breakpoint,
and the overall homology (represented as percent of total number
of homologous nucleotides in the alignment), were scored and
annotated (Table S1). In addition to the breakpoint sequence
analysis, analysis of pair-wise alignments of 49 nt in 12 regions
spanning the area of the majority of mtDNA deletions at thousand
nucleotide increments, starting at m.4500 position and ending at
m.15500, was also performed. We included the full range of
possible iterations for a total of 66 alignments.
Statistical Analysis
We used a homoscedastic Student’s t-Test with 2-tailed
distribution to determine significance in the comparison of levels
of heteroplasmy in relation to age groups and the analysis of
breakpoint homology in patients relative to random alignments.
The comparison of categorical data (presence or absence of the
common deletion) in blood versus muscle tissue was analyzed
using Fisher’s exact test. Differences were considered significant at
P,0.05.
Results
Sixty seven patients found to have an mtDNA deletion were
grouped according to age at diagnosis into 4 age groups; 0–5, 6–
20, 21–40, and older than 41 years-old for groups 1 to 4
respectively. There were 17, 18, 19, and 13 patients in each age
group, respectively. Clinical features of the patients were reviewed,
and are presented in detail in Table S1. A custom designed,
clinically validated MitoMetH array CGH was used to estimate the
deletion breakpoints and levels of heteroplasmy, followed by
PCR/DNA sequencing to identify the exact breakpoints and
deletion sizes (Figure S1 and Table S1). In some of the samples
that were analyzed prior to the availability of the MitoMetH array,
the percent heteroplasmy was estimated by densitometric analysis
of the Southern blots.
To investigate the locations of the deletion breakpoints among
the four age groups, the 59 and 39 deletion breakpoints of mtDNA
deletion patients in each age group were mapped to the
mitochondrial genome (Figure 1). The results showed an uneven
distribution. Groups 2, 3, and 4 had a very similar pattern of
deletion distribution, with the majority located near or at the
common deletion breakpoint (8470–13447 nt). The youngest age
group showed deviation from this common trend (Figure 1). As
shown in Figure 2, the distribution of breakpoints in age groups 2,
3, and 4 has a few discrete locations with the most common
breakpoint region accounting for 50–70% of overall breakpoints.
Whereas group 1 patients showed a high heterogeneity of
breakpoints and a diffused distribution, with the common
breakpoint region accounting for no more than 25% of overall
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analyzed, the observed difference in breakpoint distribution
between group 1 and other groups was not statistically significant.
The size of deletion and the number of genes deleted were similar
in all age groups (Table 1). In contrast, levels of deletion mutant
heteroplasmy showed a decreasing trend with increasing age, with
group 1 having an average of 67.9% heteroplasmy, which is
significantly higher than that of the other groups combined (42–
53% average, P=0.00069). Group 1 patient specimens were all
blood tissue, whereas the rest of the groups specimens were
predominantly (82%) muscle tissue.
The molecular characteristics of DNA sequences at the
deletion breakpoints were investigated by alignment (Figure 3)
and analysis of DNA sequences (49 nt total including 24 nt on
each side of the breakpoint plus the breakpoint nucleotide)
surrounding the two breakpoints of each sample using ClustalW
software (Table S1, Figure S2). This analysis shows the presence
of two types of breakpoints: those involving and not involving a
direct repeat. Seventy percent of mtDNA deletions involved a
direct repeat sequence (Type I). The ‘‘common deletion’’
involving the 13 nt direct repeat at the breakpoint was present
in 25 patients (25/67=37%). The second longest direct repeat
Figure 1. Distribution of deletions in age-grouped mtDNA deletion patients. X-axis represents the nucleotide position along the
mitochondrial genome, and y-axis shows deletions for individual patients arranged by the age-group and the most proximity of the left breakpoint to
the 1
st nucleotide, from top to bottom. Blue diamonds and red squares represent the left and right breakpoints respectively. Each patient sample has,
in the columns on the right, description of the presence of type 1 breakpoint (Type I BP), percent heteroplasmy (% HP), percentage of sequence
homology at breakpoints (% HL), and tissue type (Tissue).
doi:10.1371/journal.pone.0015687.g001
Molecular Analysis of mtDNA Deletion Syndromes
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15687(12 nt) involving the second most common deletion was
observed in 6 patients. Half of the patients who had no direct
repeat at the breakpoint had large direct repeats (more than
5 nt) near the breakpoint. ClustalW alignment tool was used to
estimate the sequence homology, defined as the percentage of
homologous nucleotides, in the 49 nucleotides alignment of the
proximal and distal sequences surrounding the breakpoints of
each mtDNA deletion case (Table S1). Furthermore, a majority
of samples, with or without direct repeat at the breakpoint,
showed very high sequence homology, exceeding 60% in some
cases, within the 49 nucleotides around the breakpoint (Table 1).
In fact, L of the mtDNA deletions had at least one 5 nt+ direct
repeat surrounding the breakpoints. When compared to 66
randomly aligned 49 nucleotide regions throughout the mito-
chondrial genome the degree of sequence homology within the
breakpoint region was significantly higher (Figure 4a). In
addition, the patient cohort showed a striking enrichment for
the presence of large (.8 nt) direct repeats at the breakpoints
relative to the randomly aligned sequences (Figure 4b). This
analysis revealed a significant increase (p=3610
214)i n
sequence homology around the mtDNA deletion breakpoints
above that of the mitochondrial genomic sequence background.
When analyzed independently, both Type I and Type II
breakpoints showed significant increase in homology relative to
random alignments. Type I breakpoints showed significant
(p,5.3610
224) increase in homology relative to random break-
points (52.9% vs. 40.8%). Although not as high as Type I
breakpoints, homology at Type II breakpoints (47.2%) was also
significantly (p,6.7610
25) increased compared to random
alignments. When all age groups are compared, group 1 showed
significantly (p=0.04) lower levels of sequence homology
compared to the other 3 groups combined (48.5% compared
to 52.2%), and the smallest percentage of samples with direct
repeats at breakpoints (58.8% compared to 74%) (Table 1).
Furthermore, the common deletion was present in 18% of group
1 patients, and in 44, 42, and 46% of patients in groups 2, 3, and
4, respectively (Table 1). Due to the small group sizes, statistical
analysis lacks power to determine if these differences are
significant (p=0.08). However, there was a significant difference
(p=0.0014) in the frequency of the common deletion in patients
Table 1. Analysis of molecular features of mtDNA deletions in patients separated according to age groups.
Group Age Heteroplasmy (%)
Deletion size
range and
average (Kb)
Deleted genes
(#) Type I breakpoints
Homology at
breakpoint
Samples with
common 5 kb
deletion
1 0 – 5 67.9 5.47–16.07 (5.48) 12.5 58.8 (10/17) 48.5 17.6
2 6 – 20 53.3 6.33–16.07 (6.02) 13.7 77.8 (14/18) 51.7 44.4
3 21 – 40 43.8 3.64–16.17 (5.79) 13.6 68.4 (13/19) 51.4 42.1
44 1 + 42.2 6.07–16.07 (5.44) 12.7 76.9 (10/13) 53.9 46.1
doi:10.1371/journal.pone.0015687.t001
Figure 2. Breakpoint distribution in age-grouped mtDNA deletion patients. X-axis represents the nucleotide position along the
mitochondrial genome in 200 nucleotide increments, and y-axis represents the percentage of samples with that breakpoint in BP1 and BP2 to the
total number of breakpoints in BP1 and BP2 respectively (BP1 and BP2 refer to the breakpoint locations rounded to the next 200 nt increment).
doi:10.1371/journal.pone.0015687.g002
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blood) compared to patients with neuromuscular/PEO/MM
disorders (3/26 vs. 22/41 patients, or 11.5% vs. 53.6%) (Table
S1). Clinical features were analyzed across all age groups.
Consistently, the majority of young patients (group 1) presented
with multisystem disorders or Pearson syndrome; whereas most
(68 to 78%) of older patients (groups 2, 3, and 4) were diagnosed
with MM, PEO, KSS, or multisystem involvement (Figure 5).
Figure 3. Sequence alignments of mtDNA deletion breakpoints. The two breakpoints in each mtDNA deletion sample (Prox. and Dist. Ref.)
were aligned using ClustalW alignment tool. Alignments were grouped based on the location of the breakpoint as either within a direct repeat
sequence (type I), or not within a direct repeat sequence (type II). Direct repeats are bolded and underlined. Mapped breakpoint nucleotides are in
red. Top strand in each alignment is the proximal breakpoint sequence and bottom is the distal breakpoint sequence from Table S1. Alignments
corresponding to the individual patient case from Table S1 are indicated to the left of the alignment.
doi:10.1371/journal.pone.0015687.g003
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Clinical manifestations of mtDNA deletion syndromes range
from acute, multisystem, and often lethal disorders in infants and
young children, to relatively mild neuromuscular symptoms that
are often of adult onset [8]. The underlying molecular features of
these deletions are thought to play a role in the deletion process,
and may also be related to the severity of the disorder. The aim of
this study was to investigate the molecular characteristics of
mtDNA deletions and their correlation to the age at onset and
disease clinical phenotype, with the hypothesis that specific
molecular signatures are associated with mtDNA deletion
mechanism and thus clinical manifestation. We maintain a large
clinical and molecular database of patients with mitochondrial
disorders, including a large cohort of patients with an mtDNA
deletion syndrome, which provided us with a unique opportunity
to test this hypothesis.
It has been shown previously that mtDNA deletions exhibit
enrichmentfordirectrepeatsat thebreakpoints [2,3,5,11,13,21,22].
These data have been corroborated by many groups and resulted in
stratifying these deletions as type I (with a direct repeat) or type II
(imperfect or no direct repeat) in relation to sequences at the two
breakpoints. While the presence of the repeat may play a role in
molecular events leading to an mtDNA deletion, the precise
mechanism is not clear. On the other hand, there are numerous
reports of young children severely affected with multisystem
mtDNA deletion syndrome who did not have direct repeats at the
breakpoints [8]. This prompted us to characterize deletion break-
points molecularly. Our data reveal that, regardless of the presence
of a direct repeat, most mtDNA deletion regions have a significant
increase in sequence homology surrounding the breakpoints. About
one third of the patients in this study that had type II breakpoints
nevertheless showed a significant increase in sequence homology
relative to what would be expected by chance. These data provide
evidence that sequence homology is the primary determinant of
breakpoint distribution in mtDNA deletion syndromes. Since large
direct repeats have the longest continuous stretches of sequence
homology, they would be expected to be the most frequent sites of
Figure 4. Analysis of homology at mtDNA deletion breakpoints
relative to random alignment controls. A) Percent homology
(percent of nucleotides in alignment out of total possible 49) inferred
by ClustalW at mtDNA deletion breakpoints relative to random
alignment background. The homoscedastic Student’s t-Test with 2-
tailed distribution was used to determine significance. B) Quantification
of direct repeats at breakpoints (+/2 25 nt) in mtDNA deletion
breakpoints relative to random alignment background.
doi:10.1371/journal.pone.0015687.g004
Figure 5. Clinical diagnosis and clinical manifestations in patients with mtDNA deletions. Y axix indicates the percentages of samples
with a specific clinical diagnosis indicated in Table S1.
doi:10.1371/journal.pone.0015687.g005
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which is flanked by the longest (13 nt) direct repeat, is observed in
more than one third (25/67=37%) of our patients. The second
most common deletion is flanked by the 12 nt direct repeat in six of
our patient samples. The presence of sequence homology at the
breakpoints suggests its role not only in the generation of the break
but also in the repair of mtDNA damage. It has been suggested that
repeats drive breakpoint generation when there is an error in
mtDNA replication dueto inappropriate alignment of directrepeats
[12,13,14], or a mtDNA damage [15]. Both, defects in mtDNA
replication caused by inappropriate alignment of direct repeats
[12,13,14] and mis-annealing of a single strand mtDNA molecule
following double stranded breaks [15] require the presence of direct
repeats or sequence homology.
Although significantly higher than random mitochondrial
genome homology, the youngest age group 1 showed significantly
lower breakpoint homology relative to the older age groups.
Furthermore, group 1 patients harbored a significantly lower
percentage of samples with type I breakpoints (Table 1), and
almost 3-fold decreased incidence of the common 5 kb mtDNA
deletion relative to other three age groups, as well as increased
heterogeneity in breakpoint distribution. However, disease severity
is not affected by the size of deletion and genes deleted. These data
suggest that molecular events responsible for mtDNA deletions in
young patients may differ from those found in older age groups.
One possibility is that mtDNA deletions in these patients are
inherited from maternal germ line mutations, or are acquired
during early embryogenesis, while the mtDNA deletions in older
age groups represent later somatic random events. This is
consistent with the clinical data obtained from these patients,
where the vast majority of young patients present with the
multisystem disease, while older age groups predominantly display
a KSS spectrum or myopathy phenotype. Significantly increased
levels of heteroplasmy in young patients relative to the older age
groups provide further evidence for this hypothesis. Consistent
with an earlier embryonic occurrence of the deletions, we have
previously shown that levels of heteroplasmy for mtDNA deletions
in young patients are present at similar levels in blood, muscle, skin
and other tissues [8], whereas mtDNA deletions are almost
exclusively localized to neuromuscular tissues in older patients.
Whether there is interplay between the tissue specificity and the
molecular mechanism of mtDNA rearrangement is not clear. It is
possible that proteins involved in DNA rearrangement are
differentially expressed in rapidly dividing/actively differentiating
cells and non-dividing muscle and brain cells.
There is a significant difference (p,0.0014) in the frequency of
the common deletion in patients with multisystem disorders (where
the deletion is detected in blood) compared to patients with
neuromuscular/PEO/MM disorders (11.5 versus 53.6%), further
suggesting a different molecular mechanism for mtDNA rear-
rangement between germ cells and somatic cells. MtDNA
deletions in germ cells may be driven by DNA replication, while
mtDNA deletions in postzygotic somatic cells may be due to mis-
pairing of homologous regions during repair of random oxidative
mtDNA damage.
A recent study of mtDNA deletions in aged human skeletal
muscle fibers has reported an increased incidence of mtDNA
deletions with the presence of direct repeats compared to no direct
repeats at breakpoints in older (.60 years old) relative to younger
individuals [23]. The authors proposed that oxidative-damage
induced DNA-replication errors resulting in mtDNA deletions
accumulated up to a pathological threshold over time. Presumably
there would be a higher frequency of deletions at the direct-repeat
hotspots that would selectively accumulate and be predominant
over time. Conversely, a study of mtDNA deletion in substantia
nigra neurons of age-matched patients with Parkinson Disease,
mtDNA multiple deletion disorder, and single deletions, showed
no difference in the type of deletion breakpoints in these samples,
suggesting that a similar mechanism may be involved [24].
Krishnan and colleagues suggested that increased reactive oxygen
species produced in these neurons could cause double strand
breaks through DNA damage or replication stalling, and proposed
aberrant DNA repair as a mechanism for mtDNA deletion
formation [15]. Further support for this mechanism comes from a
study in which restriction endonuclease PstI-induced breakpoints
resulted in the formation of mtDNA deletions flanked by short
sequences with or without direct repeats [25]. A common theme
across all these studies is the detection of increased degree of
sequence homology around the breakpoints of mtDNA deletions
with breakpoints containing direct repeats, imperfect repeats, or
no repeats at the breakpoint. Our data support these findings,
and further demonstrate that a common feature of the break-
points, irrespective of the type, is a significantly increased
sequence homology around the breakpoint. Similar to the DNA
replication model of mtDNA deletions, DNA break repair models
rely on miss-annealing of the short homologous sequences in the
single stranded DNA molecule, which in the latter case would be
generated via 39 to 59 exonuclease activity. Three major types of
error-prone double-strand breakpoint repair in the context of
genomic DNA include non-homologous endjoining (NHEJ),
microhomology-mediated end joining (MMEJ), and single-strand
annealing (SSA). NHEJ was shown to rely on small (1–4 nt)
homologies resulting in small ,5 nt deletions/insertions, while
MMEJ involves larger (5–25) nucleotide homologies that may or
may not be direct repeats and can result in larger deletions
[20,26,27]. SSA requires direct repeats .30 nt. Therefore,
MMEJ-type double-strand break repair mechanism would most
closely fit the criteria based on the type of deletions seen in the
mtDNA. The mitochondrial proteins that may be involved
include mitochondrial polymerase gamma (POLG1) and SFN
which are known to have a 39 to 59 exonuclease activity and are
targeted to mitochondria [28,29,30]. Another mechanism named
microhomology-mediated break-induced replication (MMBIR),
involving small (2–5 nt) homologous sequences at or near the
breakpoint junctions, was recently proposed to be involved in
human copy number variance (CNV) formation, and could
theoretically be involved in mtDNA deletions [31]. This
mechanism is based on the assumption that during DNA
replication, single stranded DNA breaks would generate single-
stranded 39 tails which could anneal with any single-stranded
homologous DNA nearby and thereby would induce DNA
rearrangements.
In conclusion, breakpoint sequence homology is a consistent
feature of most mtDNA deletions. These data also suggest that the
underlying molecular signatures determine the mtDNA deletion
mechanism and may also correlate with clinical manifestations in
patients with a mtDNA deletion syndrome. While we are still far
from fully understanding the molecular mechanisms underlying
these disorders, certain specific molecular features such as
increased percentage of heteroplasmy, relatively lower homology
at breakpoints, and a decreased frequency of the common
deletions, may play a role in the severity and earlier age of onset
of mtDNA deletion syndromes.
Supporting Information
Figure S1 Mapping of mtDNA breakpoints. A) The
position of the mtDNA deletion and level of heteroplasmy was
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PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15687determined using the clinical MitoMet array using a previously
published protocol [18]. Y-axis shows the position of the probes
along the mitochondrial chromosome. The location and the level
of heteroplasmy was calculated based on normalized probe
intensity to age and tissue matched controls. B) Based on the
MitoMet results mtDNA was PCR amplified and sequenced across
the breakpoint to determine the precise nucleotides involved in the
breakpoint. Top sequence represents sequence 59 to the break-
point and bottom sequence represents the sequence 39 to the
breakpoint. Middle sequence is sequence across the patient’s
breakpoint
(TIFF)
Figure S2 Analysis of sequence homology at mtDNA
deletion breakpoints. The two breakpoints in each mtDNA
deletion sample (Prox. and Dist. Ref.) were aligned using ClustalW
alignment tool. Alignments were grouped based on the location of
the breakpoint as either within a direct repeat sequence (type I), or
not within a direct repeat sequence (type II). Direct repeats of 5+
nucleotides are highlighted (dark grey), and repeats of smaller size
are highlighted (light gray). Mapped breakpoint nucleotides are in
red. ClustalW alignments where the breakpoints do not align (in
Type II breakpoints) are because, ClustalW alignment shifts the
alignment to achieve maximum homology in that region. Top
strand in each alignment is the proximal breakpoint sequence and
bottom is the distal breakpoint sequence from Table S1.
Alignments corresponding to the individual patient case from
Table S1 are indicated to the left of the alignment.
(TIFF)
Table S1 The ‘‘breakpoint nucleotide’’ refers to the nucleotide
position at which the breakpoint has occurred, either in the 59 or
the 39 position. A majority of the subjects analyzed have either a
single nucleotide, or a stretch of identical nucleotides (direct
repeats), present at the two breakpoints flanking the deletion. As
such, the sequence alignment of the breakpoints does not allow us
to predict if the breakpoint happens at the 59 or the 39 of the
overlapping nucleotide/s at the breakpoint 1 and 2 respectively.
We refer to the common region of overlap as the ‘‘breakpoint
nucleotide’’. The breakpoint nucleotide is indicated in columns
proximal breakpoint reference sequence (59 to 39) and distal
breakpoint sequence (59 to 39) with ‘‘[ ]’’. In cases with direct
repeats at breakpoints, which are longer than 1 nucleotide, the
most 59 nucleotide of the direct repeat is indicated with the
bracket. These correspond to the nucleotides that are labeled in
red color in Figure 3 and Figure S2. The sequences in the
Proximal breakpoint reference sequence column which are 39
from the breakpoint nucleotide, and sequences in the Distal
breakpoint sequence column which are 59 from the breakpoint
nucleotide represent the 59 and 39 sequences of the deleted
molecule respectively. In cases where there is not a common
nucleotide(s) at the two breakpoints, the sequence breakpoint is
predicted to be 39 to the breakpoint nucleotide in the breakpoint 1
sequence, and 59 to the breakpoint nucleotide in the breakpoint 2
sequence. All sequences are presented in 59 to 39 direction, left to
right.
(XLSX)
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